Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: An observational study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Sangsari, Sassan ^a   Milloy, M J ^a,b   Ibrahim, Amir ^a   Kerr, Thomas ^a,b   Zhang, Ruth ^b   Montaner, Julio ^a,b   Wood, Evan ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG; METHADONE; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; STREET DRUG;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DRUG ABUSE; EXPERIENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHYSICIAN EXPERIENCE; TREATMENT RESPONSE; VIRUS INHIBITION; ADOLESCENT; DRUG USE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PROFESSIONAL COMPETENCE; STATISTICS; TIME; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; DRUG USERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROFESSIONAL COMPETENCE; STREET DRUGS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84856106530     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-22     Document Type: Article

References (19)

1. Joint United Nations Programme on HIV/AIDS UNAIDS report on the global AIDS epidemic 2010. Joint united nations programme on HIV/AIDS (UNAIDS). Geneva, Switzerland 2011, Joint United Nations Programme on HIV/AIDS.
2. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372(9651):1733-1745. 10.1016/S0140-6736(08)61311-2, 18817968.
3. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Gunthard HF, Hammer SM, Hirsch MS, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010, 304(3):321-333. 10.1001/jama.2010.1004, 20639566.
4. Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002, 31(Suppl 3):S112-117.
5. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002, 17(5):377-381. 1495042, 12047736.
6. Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis 2004, 39(8):1190-1198. 10.1086/424008, 15486844.
7. Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med 2005, 165(6):618-623. 10.1001/archinte.165.6.618, 15795336.
8. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998, 280(6):547-549. 10.1001/jama.280.6.547, 9707146.
9. Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, Montaner JS. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA 2008, 300(5):550-554. 10.1001/jama.300.5.550, 18677027.
10. Gross R, Yip B, Lo Re V, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JS, Hogg RS. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006, 194(8):1108-1114. 10.1086/507680, 16991085.
11. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138(11):923-936.
12. Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, Montaner J, Wood E. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis 2011, 203(9):1215-1221. 10.1093/infdis/jir032, 21459814.
13. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996, 334(11):701-706. 10.1056/NEJM199603143341106, 8594430.
14. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS 2003, 17(5):711-720. 10.1097/00002030-200303280-00009, 12646794.
15. Escaffre N, Morin M, Bouhnik AD, Fuzibet JG, Gastaut JA, Obadia Y, Moatti JP. Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs. AIDS Care 2000, 12(6):723-730. 10.1080/09540120020014264, 11177451.
16. Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, Ma Y, Kaplan AH, Wenger NS. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?. J Gen Intern Med 2002, 17(1):1-11. 10.1046/j.1525-1497.2002.09004.x, 1494993, 11903770.
17. Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 2006, 84(2):188-194. 10.1016/j.drugalcdep.2006.02.003, 16542797.
18. Engelbach U, Dannecker M, Kaufhold J, Lenz C, Grabhorn R. Adherence as a result of a "particular relationship". HIV-infected patients about their physician-patient relationship. Psychother Psychosom Med Psychol 2008, 58(6):e1-e14. 10.1055/s-2007-986320, 18240115.
19. Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med 2008, 9(7):503-507. 10.1111/j.1468-1293.2008.00582.x, 18484977.